| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1efd3deb963490a048f19cfc08b8267d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4283
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 |
| filingDate |
1996-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2000-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b882335c5dcbda9422d5ec0d8d5a21c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb9b92739114b24dcb42b683e5b01dfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6d24158735aa001c86885097f96eba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_247a9499324efba1bf1c1c492f85da85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b5e2338d1f8c3e975f13aa2bb578a5a |
| publicationDate |
2000-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6030614-A |
| titleOfInvention |
Ameliorating immunological rejection of allograft |
| abstract |
The invention provides a method to prevent or ameliorate hyperacute or acute rejection of a human donor organ transplanted to a human recipient. Hyperacute rejection would normally occur after a human subject receives a transplanted human organ against which the subject has preformed anti-HLA antibodies. Acute rejection occurs when the recipient of a human organ forms antibodies against that organ after transplant. The invention method comprises passing the plasma of the recipient over a sterile and pyrogen-free column coupled to anti-human immunoglobulin antibodies which bind to and remove a significant portion of the immunoglobulin from the subject's plasma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010158893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019351126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7682793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006030027-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006017763-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004208865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6126791-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014284274-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012039886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006017763-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219613-A1 |
| priorityDate |
1994-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |